DUBLIN--(BUSINESS WIRE)--Regulatory News:
Mainstay Medical International plc (Mainstay or the Company, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system to treat disabling Chronic Low Back Pain, announces that Chief Executive Officer, Peter Crosby, will present at the Wedbush PacGrow 2016 Healthcare Conference at the Le Parker Meridien in New York City, on Wednesday, 17 August 2016 at 10:55am EDT (15:55 BST; 16:55 CET).
A live audio webcast of the presentation will be made available on the Investors section of the Company’s website and at http://wsw.com/webcast/wedbush32/msty.pa, with an archived version available for up to 90 days following the live presentation.
If you would like to meet with Mainstay management at or around this event, please contact the event organizers or investor-relations@mainstay-medical.com
- End -
About Mainstay
Mainstay is a medical device company focused on bringing to market an innovative implantable neurostimulation system, ReActiv8®, for people with disabling Chronic Low Back Pain (CLBP). The Company is headquartered in Dublin, Ireland. It has subsidiaries operating in Ireland, the United States, Australia and Germany, and its ordinary shares are admitted to trading on Euronext Paris (MSTY.PA) and the ESM of the Irish Stock Exchange (MSTY.IE).
Further information can be found at www.mainstay-medical.com
CAUTION – in the United States, ReActiv8 is limited by federal law to investigational use only.